Q1 2023 Holdings
Filed 2023-05-15 | 25 holdings | $512.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $68.7M | 2,699,865 | 13.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $52.7M | 4,884,977 | 10.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $48.5M | 2,214,142 | 9.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $42.9M | 3,619,522 | 8.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $38.0M | 1,430,000 | 7.4% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $29.4M | 3,298,577 | 5.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $28.1M | 3,517,125 | 5.5% |
| Dice Therapeutics Inc | COM | 23345J104 | $23.5M | 819,000 | 4.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $22.9M | 2,916,667 | 4.5% |
| Merus N V | COM | N5749R100 | $22.6M | 1,226,214 | 4.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $21.6M | 2,105,386 | 4.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $16.8M | 833,927 | 3.3% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $16.3M | 1,973,251 | 3.2% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $15.9M | 1,866,000 | 3.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.4M | 3,220,050 | 2.4% |
| Savara Inc(SVRA) | COM | 805111101 | $12.4M | 6,351,531 | 2.4% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $8.7M | 2,208,812 | 1.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.4M | 1,040,754 | 1.6% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $6.8M | 770,000 | 1.3% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.6M | 3,050,022 | 1.1% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.7M | 1,307,094 | 0.7% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $1.9M | 924,170 | 0.4% |
| Avalo Therapeutics Inc | COM NEW | 05338F207 | $1.8M | 1,000,000 | 0.3% |
| Rallybio Corp | COM | 75120L100 | $1.5M | 268,532 | 0.3% |
| Affimed N V | COM | N01045108 | $1.1M | 1,428,571 | 0.2% |